Click on headlines below to download research

Transformative 2020; solid fundamentals for 2021
Ergomed | 23/03/2021

Ergomed’s FY20 results released today showed that adjusted EBITDA of £19.4m was 4.2% ahead of our estimate. This was a positive surprise after…

PrimeVigilance excels; CRO strengthened in US
Ergomed | 26/01/2021

Ergomed’s H220 trading update highlights a successful end to 2020 despite the COVID-19 pandemic causing restrictions for much of the year. Total…

MedSource acquisition to boost US CRO business
Ergomed | 14/12/2020

Today Ergomed announced it has agreed to acquire US-based MedSource. Headquartered in Houston, Texas, MedSource is a full-service clinical research organisation…